Posted on 03/11/21
| News Source: Times of Israel
Pfizer-BioNTech’s coronavirus vaccine offers more protection than previously thought, with its effectiveness in preventing symptomatic disease reaching 97 percent according to real-world evidence published Thursday by the pharmaceutical companies.
Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more
Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens
Using data from January 17 to March 6 from Israel’s national vaccination campaign, Pfizer-BioNTech found that prevention against asymptomatic disease reached 94.
“This comprehensive real-world evidence… can be of importance to countries around the world as they advance their own vaccination campaigns one year after the World Health Organization declared COVID-19 a pandemic,” the two pharmaceutical companies said in a statement.
Read more at Times of Israel